US68375N1037 - Common Stock
OPKO HEALTH INC
NASDAQ:OPK (4/19/2024, 7:08:18 PM)
After market: 1.21 -0.02 (-1.63%)1.23
0 (0%)
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. The company is headquartered in Miami, Florida and currently employs 4,196 full-time employees. The firm's segments include diagnostics and pharmaceuticals. The diagnostics segment consists of the clinical laboratory operations of BioReference Health, LLC (BioReference), its point-of-care operations. The pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. Through BioReference, it operates laboratory divisions, such as BioReference Health, GenPath and GenPath. Its Pharmaceutical Business has one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including pharmaceutical compounds, Oxyntomodulin, Biologics, Factor VIIa-CTP and others. The company also owns an active pharmaceutical ingredients manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.
OPKO HEALTH INC
4400 Biscayne Blvd.
Miami FLORIDA 33137
P: 13055754181
CEO: Phillip Frost
Employees: 4196
Website: https://www.opko.com/
/PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational...
• Study delivers first clinical safety and pharmacokinetic data as proof of concept for the use of multispecific antibodies in humans• Candidate showed...
/PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL, NXPLW) ("NextPlat" or the "Company"), a global e-Commerce provider, today announced that its exclusive OPKO...
OPK earnings call for the period ending December 31, 2023.
OPKO Health's Q4 financial results surpass expectations with a beat of $0.01 on EPS and $4.37M on revenue, despite a slight year-over-year decline.
Here you can normally see the latest stock twits on OPK, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: